Market Tracker

04/17 6:05pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

During the Trading Day
1.50 0.00 / 0.00%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.50 0.00 / 0.00%
 
Volume: 7.2K

Today’s Trading

Previous close1.50
Today’s open1.50
Day’s range1.46 - 1.53
Volume1,116,203
Average volume (3 months)3,902,426
Market cap$423.2M
Dividend yield--
Data as of 4:00pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+7.32%
Earnings growth (this year)+24.74%
Earnings growth (next 5 years)--
Revenue growth (last year)+15.82%
P/E ratioNM
Price/Sales34.19
Price/Book2.27

Competitors

 Today’s
change
Today’s
% change
TKMRTekmira Pharmaceutic...-0.93-6.65%
CHTPChelsea Therapeutics...-0.03-0.63%
RGENRepligen Corp+0.44+2.86%
PETXAratana Therapeutics...+0.42+3.10%
Data as of 4:00pm ET, 04/17/2014

Financials

Next reporting dateMay 8, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$11.3M
Annual profit (last year)-$66.7M
Net profit margin-593.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts